NCT01194583

Brief Summary

The study's major aim is to investigate the ability of a commercial Electronic Nicotine Delivery Device (E-Cigarette) to induce long-term smoking reduction/abstinence in smokers unwilling to quit. Secondary aims are to investigate changes in withdrawal symptoms and cravings and to examine whether concomitant use of the E-Cigarette and smoking is safe. The study will monitor smoking reduction/abstinence effects, changes in withdrawal symptoms, and adverse events of a currently marketed device in Italy ("Categoria" electronic cigarette - "NO nicotine" cartridges). The primary hypothesis is that the E-Cigarette is a safe device that allows smoking reduction or abstinence in smokers possibly by suppressing withdrawal symptoms and cravings independently from nicotine delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 3, 2010

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

January 8, 2013

Status Verified

January 1, 2013

Enrollment Period

2 years

First QC Date

September 2, 2010

Last Update Submit

January 7, 2013

Conditions

Keywords

electronic cigarettenicotinesmoking cessationsmoking reduction

Outcome Measures

Primary Outcomes (2)

  • Sustained 50% reduction in the number of cigarettes smoked per day at week-12 from baseline

    50% reduction in the number of cigarettes smoked per day documented at each study visit (week-2, -4, -6, -8, -10, and -12)

    week-12

  • Sustained smoking abstinence at week-12

    Sustained smoking abstinence at week-12, defined as complete abstinence from tobacco smoking (not even a puff) for the 14 days period prior to week-12 study visit; exhaled CO levels will be measured to objectively verify smoking status.

    week 12

Secondary Outcomes (7)

  • Sustained 80% reduction in the number of cigarettes smoked per day at week-12 from baseline

    week-12

  • Sustained smoking abstinence at week-24

    week 24

  • Sustained 50% reduction in the number of cigarettes smoked per day at week-24 from baseline

    week-24

  • Sustained 80% reduction in the number of cigarettes smoked per day at week-24 from baseline

    week-24

  • Withdrawal suppression (by MNWS)

    24 weeks

  • +2 more secondary outcomes

Study Arms (1)

NO NICOTINE

Well characterized group of 100 regular smokers experimenting the E-Cigarette without nicotine cartridges (NO nicotine group).

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Regular smokers from Catania in Italy recruited following the placement of an advertisement in a local newspaper.

You may qualify if:

  • healthy smokers unwilling to quit, between 18 and 60 years of age. They should report a cigarette intake of ≥ 15 cig/day for at least 5 years. At screening they must provide a CO level of ≥ 15 ppm and an FTND ≥ 5.

You may not qualify if:

  • alcohol and illicit drug use, breastfeeding, or pregnancy. Individuals who report current attempts to quit smoking and previous experience with electronic cigarettes will be also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dipartimento di Medicina Interna e Specialistica; Centro per la Prevenzione e Cura del Tabagismo (CPCT)

Catania, 95124, Italy

Location

MeSH Terms

Conditions

Smoking CessationVapingSmoking Reduction

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorSmoking

Study Officials

  • Riccardo Polosa, MD, PhD

    Università di Catania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Internal Medicine

Study Record Dates

First Submitted

September 2, 2010

First Posted

September 3, 2010

Study Start

April 1, 2010

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

January 8, 2013

Record last verified: 2013-01

Locations